Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Italy / NCT07743177
Active, not recruiting Observational

Auditory Brainstem Evoked Potentials in Autism Spectrum Disorder

NCT07743177 · tracked via the Priya Life Science Italy tracker
Sponsor
IRCCS National Neurological Institute "C. Mondino" Foundation
Phase
Observational
Started
2026-03-31
Last updated
2026-08-03

Condition(s) studied

Autism Spectrum Disorder

Study summary

This retrospective study investigates auditory brainstem evoked potentials (BAEPs) in children with autism spectrum disorder (ASD) compared with other neuropsychiatric conditions. The study aims to evaluate differences in BAEP parameters, with particular attention to sex- and age-related effects and clinical severity

Eligibility

Sex
ALL
Min age
2 Years
Max age
5 Years
Healthy volunteers
No
Inclusion Criteria: * Children aged 2-5 years * BAEP examination performed at IRCCS Fondazione Mondino between January 2021 and December 2023 * Diagnosis/Suspicion of autism spectrum disorder or other neuropsychiatric conditions * Availability of technically reliable BAEP recordings Exclusion Criteria: * Non-interpretable BAEP recordings due to lack of cooperation

Primary outcome measure(s)

  • Differences in BAEP interpeak intervals (I-III, III-V, I-V) — Single assessment at admission between 2021 and 2023 (retrospective analysis)
    Differences in BAEP interpeak intervals (I-III, III-V, I-V) between children with ASD and other neuropsychiatric conditions
  • Differences in BAEP wave latencies (I, III, V) — Single assessment at admission between 2021 and 2023 (retrospective analysis)
    Differences in BAEP wave latencies (I, III, V) and interpeak intervals (I-III, III-V, I-V) between children with ASD and other neuropsychiatric conditions

Trial sites (1)

FacilityCityRegionStatus
Translational Neurophysiology Pavia Italy

More IRCCS National Neurological Institute "C. Mondino" Foundation trials in Italy

Integrating AI in Postural Rehabilitation for Parkinson's Disease Recruiting
Multiple Sclerosis and the Effects of Ketogenic Diet Therapy Recruiting
Idiopathic Generalized Epilepsy Cognitive and Emotional Profile Recruiting
Phrenic Nerve and Diaphragm Electrophysiology in Pompe Disease Recruiting
Effect of Cognitive Behavioral Play Intervention and Epilepsy Recruiting

Other trials for the same condition

The Impact of Sensory Integration on Attention in Autism Recruiting
Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients Recruiting
Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents Active, not recruiting
"Sleep Patterns and EEG Structure in Youth With Autism: Links With Behavior and Parental Stress" Active, not recruiting
Early Neurodivergent Developmental Trajectories in Autism and in Response to the ESDM Intervention Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07743177 on ClinicalTrials.gov ↗ ← All trials in Italy